84 related articles for article (PubMed ID: 20060467)
1. Improving sublingual delivery of weak base compounds using pH(max) concept: application to propranolol.
Wang Y; Zuo Z; Chen X; Tomlinson B; Chow MS
Eur J Pharm Sci; 2010 Feb; 39(4):272-8. PubMed ID: 20060467
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of buffered propranolol sublingual tablet (Promptol™)-application of a new "physiologically based" model to assess absorption and disposition.
Wang Y; Wang Z; Zuo Z; Tomlinson B; Lee BT; Bolger MB; Chow MS
AAPS J; 2013 Jul; 15(3):787-96. PubMed ID: 23605805
[TBL] [Abstract][Full Text] [Related]
3. HO-1-u-1 model for screening sublingual drug delivery--influence of pH, osmolarity and permeation enhancer.
Wang Y; Zuo Z; Chow MS
Int J Pharm; 2009 Mar; 370(1-2):68-74. PubMed ID: 19071203
[TBL] [Abstract][Full Text] [Related]
4. In silico model of drug permeability across sublingual mucosa.
Goswami T; Kokate A; Jasti BR; Li X
Arch Oral Biol; 2013 May; 58(5):545-51. PubMed ID: 23123066
[TBL] [Abstract][Full Text] [Related]
5. Is epinephrine administration by sublingual tablet feasible for the first-aid treatment of anaphylaxis? A proof-of-concept study.
Gu X; Simons KJ; Simons FE
Biopharm Drug Dispos; 2002 Jul; 23(5):213-6. PubMed ID: 12116053
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
[TBL] [Abstract][Full Text] [Related]
7. A rabbit model for sublingual drug delivery: comparison with human pharmacokinetic studies of propranolol, verapamil and captopril.
Dali MM; Moench PA; Mathias NR; Stetsko PI; Heran CL; Smith RL
J Pharm Sci; 2006 Jan; 95(1):37-44. PubMed ID: 16307454
[TBL] [Abstract][Full Text] [Related]
8. Effect of Lipophilicity and Drug Ionization on Permeation Across Porcine Sublingual Mucosa.
Goswami T; Li X; Jasti BR
AAPS PharmSciTech; 2017 Jan; 18(1):175-181. PubMed ID: 26931443
[TBL] [Abstract][Full Text] [Related]
9. Mucoadhesive polymers-based film as a carrier system for sublingual delivery of glutathione.
Chen G; Bunt C; Wen J
J Pharm Pharmacol; 2015 Jan; 67(1):26-34. PubMed ID: 25303221
[TBL] [Abstract][Full Text] [Related]
10. Predictivity of standardized and controlled permeation studies: Ex vivo - In vitro - In vivo correlation for sublingual absorption of propranolol.
Majid H; Bartel A; Burckhardt BB
Eur J Pharm Biopharm; 2021 Dec; 169():12-19. PubMed ID: 34508807
[TBL] [Abstract][Full Text] [Related]
11. Effect of pH on sublingual absorption of oxycodone hydrochloride.
Al-Ghananeem AM; Malkawi AH; Crooks PA
AAPS PharmSciTech; 2006 Mar; 7(1):E23. PubMed ID: 16584154
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic analysis of pH-dependent solubility and trans-membrane permeability of amphoteric compounds: application to sildenafil.
Wang Y; Chow MS; Zuo Z
Int J Pharm; 2008 Mar; 352(1-2):217-24. PubMed ID: 18068319
[TBL] [Abstract][Full Text] [Related]
13. Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxis.
Rawas-Qalaji MM; Simons FE; Simons KJ
J Allergy Clin Immunol; 2006 Feb; 117(2):398-403. PubMed ID: 16461140
[TBL] [Abstract][Full Text] [Related]
14. Absorption kinetics of sublingually administered propranolol.
Kates RE
J Med; 1977; 8(6):393-402. PubMed ID: 272433
[TBL] [Abstract][Full Text] [Related]
15. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of a once-daily extended-release formulation of pramipexole in healthy male volunteers: three studies.
Jenner P; Könen-Bergmann M; Schepers C; Haertter S
Clin Ther; 2009 Nov; 31(11):2698-711. PubMed ID: 20110012
[TBL] [Abstract][Full Text] [Related]
17. Human bioavailability of propranolol from a matrix-in-cylinder system with a HPMC-Gelucire core.
Mehuys E; Remon JP; Korst A; Van Bortel L; Mols R; Augustijns P; Porter C; Vervaet C
J Control Release; 2005 Oct; 107(3):523-36. PubMed ID: 16055224
[TBL] [Abstract][Full Text] [Related]
18. Oramucosal delivery of LHRH: pharmacokinetic studies of controlled and enhanced transmucosal permeation.
Nakane S; Kakumoto M; Yukimatsu K; Chien YW
Pharm Dev Technol; 1996 Oct; 1(3):251-9. PubMed ID: 9552307
[TBL] [Abstract][Full Text] [Related]
19. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
[TBL] [Abstract][Full Text] [Related]
20. Disintegration of sublingual tablets: proposal for a validated test method and acceptance criterion.
Weda M; van Riet-Nales DA; van Aalst P; de Kaste D; Lekkerkerker JF
Pharmeur Sci Notes; 2006 Dec; 2006(2):41-4. PubMed ID: 17691213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
